• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Frontiers Retracts 2021 Heart Failure Study Over Figure Integrity Concerns

by
November 19, 2026
in Biology
Reading Time: 2 mins read
0
Frontiers Retracts 2021 Heart Failure Study Over Figure Integrity Concerns

Frontiers Retracts 2021 Heart Failure Study Over Figure Integrity Concerns

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The journal Frontiers in Bioengineering and Biotechnology has formally retracted a 2021 research study examining the therapeutic effects of mesenchymal stem cell extracellular vesicles on doxorubicin-induced heart failure.

According to the official retraction notice published in November 2026, concerns were raised following original publication regarding the integrity of images presented across the published figures.

During the inquiry, the authors were contacted and given the opportunity to respond to the identified image discrepancies. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies.

Following the conclusion of the inquiry, the formal retraction was approved by the Chief Executive Editor of Frontiers. Official communications regarding the decision and the authors’ opportunity to respond have been archived by the publisher as part of the formal case record. The editorial office stated that the retraction notice was received and accepted on October 22, 2026, before formal release in the journal’s Cell and Gene Therapy section.

The journal thanked the users on PubPeer for bringing the published article to its attention.

This is an open-access article distributed under the terms of the Creative Commons Attribution License.

The retraction was approved by Frontiers in Bioengineering, Frontiers Media SA, Switzerland. Correspondence is directed to the Frontiers Editorial Office at research.integrity@frontiersin.org. The official citation record catalogues the retraction under volume fourteen, article identifier 2037783, following its formal acceptance on October 22, 2026, and subsequent release on November 19, 2026.

Under the publisher disclaimer, all assertions and claims expressed within the article belong solely to the contributing authors rather than representing the views of their affiliated organizations, the journal, its editors, or its peer reviewers. Additionally, the publisher explicitly notes that any commercial product evaluated or manufacturer claim cited is neither guaranteed nor endorsed.

Distribution of the document follows Creative Commons Attribution licensing standards. This license permits reproduction and dissemination across other forums only if the original authors and copyright holders receive proper attribution, the original journal publication is formally cited, and all actions fully comply with established academic practices and license terms.

Subject of Research: Retraction of scientific study on mesenchymal stem cell extracellular vesicles in heart failure

Article Title: Retraction: Extracellular vesicles derived from human umbilical cord mesenchymal stem cells protect against DOX-induced heart failure through the miR-100-5p/NOX4 pathway

Article References: Frontiers Editorial Office (2026). Retraction: Extracellular vesicles derived from human umbilical cord mesenchymal stem cells protect against DOX-induced heart failure through the miR-100-5p/NOX4 pathway. Frontiers in Bioengineering and Biotechnology, 14, Article 2037783. https://doi.org/10.3389/fbioe.2026.2037783

Image Credits: AI Generated

DOI: 10.3389/fbioe.2026.2037783

Keywords: Retraction, Frontiers in Bioengineering and Biotechnology, PubPeer, Image Integrity, Research Ethics, Extracellular Vesicles, Mesenchymal Stem Cells, Heart Failure, Doxorubicin, Cell and Gene Therapy, Scientific Integrity, Editorial Policy, Data Integrity, Post-Publication Review, Stem Cell Research

News Source: Gregory Coleman. (November 19, 2026). Frontiers Retracts 2021 Heart Failure Study Over Figure Integrity Concerns. Scienmag.

Tags: cell and gene therapydata integritydoxorubicineditorial policyextracellular vesiclesFrontiers in Bioengineering and Biotechnologyheart failureimage integritymesenchymal stem cellspost-publication reviewPubPeerresearch ethicsRetractionscientific integritystem cell research
Share12Tweet7Share2ShareShareShare1

Related Posts

Rising Seas Threaten Coastal Forest and Wetland Corridors in Southeast US

Rising Seas Threaten Coastal Forest and Wetland Corridors in Southeast US

November 19, 2026
Northward Range Shifts Can Counteract Earlier Spring Bird Migration Passage Trends

Northward Range Shifts Can Counteract Earlier Spring Bird Migration Passage Trends

November 19, 2026

Lapsi Fruit Extract Modulates Immune Defenses and Suppresses Inflammatory Pathways in Mice

November 19, 2026

Ecological Fitness Framework Guides Postharvest Biocontrol Yeast and Microbial Community Design

November 19, 2026

POPULAR NEWS

  • Cyanoacrylate Adhesives Speed Extraoral Skin Closure but Certainty Remains Low

    Cyanoacrylate Adhesives Speed Extraoral Skin Closure but Certainty Remains Low

    29 shares
    Share 12 Tweet 7
  • Mid-size Unmanned Ground Vehicles Face Severe Mobility and Scalability Constraints

    29 shares
    Share 12 Tweet 7
  • Computational Framework Matches Biodegradable Implant Resorption Rates to Bone Healing Timelines

    29 shares
    Share 12 Tweet 7
  • Robotic Exoskeleton Gait Training Earns High Satisfaction Despite Wearability and Cost Challenges

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Lower Estimated Fitness Linked to Cardiometabolic Multimorbidity in Older Adults

Tri-Doped Titanium Dioxide Narrows Band Gap to Boost Visible-Light Absorption

Rising Seas Threaten Coastal Forest and Wetland Corridors in Southeast US

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.